AI filing briefs · archive

8-K filings in September 2025, explained

427 material Form 8-K filings that 376 companies we cover made with the SEC in September 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

13 of 427 briefs match

newest first · times in ET
ALGTAllegiant Travel CO Sep 4, 8:03 PM ET

Allegiant closes $200 million sale of Sunseeker Resort to Blackstone affiliates

Neutral m&a Written later 1.012.01

Allegiant Travel Company closed the sale of its Sunseeker Resort at Charlotte Harbor, Aileron Golf Course and related Southwest Florida properties to affiliates of Blackstone Real Estate Group on September 4, 2025. The company received cash proceeds of $200 million, less various closing adjustments, and expects to use the proceeds to pay down corporate debt and for general corporate purposes.

  • Buyers: affiliates of Blackstone Real Estate Group; the filing states no material relationship with Allegiant apart from this transaction
  • Gross cash proceeds of $200 million at closing, less unspecified closing adjustments
  • Proceeds expected to be used to pay down corporate debt and for other general corporate purposes
Read the filing on SEC.gov ↗
CCSCentury Communities, Inc. Sep 4, 5:18 PM ET

Century Communities prices $500 million senior notes due 2033 to redeem 2027 notes

Neutral financing Written later 1.018.01

Century Communities agreed to sell $500 million of 6.625% Senior Notes due 2033 in a private offering, expected to close September 17, 2025. The company plans to use the net proceeds of about $494 million, plus cash on hand, to fund the redemption of all $500 million of its 6.750% Senior Notes due 2027. The filing describes a refinancing of existing debt rather than a change in operations, and the filing does not report earnings or guidance.

  • Notes: $500 million principal, 6.625% interest, due 2033, sold at 100% of principal
  • Expected net proceeds of about $494 million after initial purchasers' discounts and fees
  • Proceeds plus cash on hand to fund redemption of all $500.0 million of 6.750% Senior Notes due 2027
  • Offering expected to close September 17, 2025, subject to customary closing conditions
Read the filing on SEC.gov ↗
SLGNSILGAN HOLDINGS INC Sep 4, 5:00 PM ET

Silgan prices €600 million 4.25% senior notes due 2031 in private offering

Neutral financing Written later 1.018.01

Silgan Holdings agreed on September 3, 2025 to sell €600 million of 4.25% senior notes due 2031 at 100 percent of principal, with closing expected on or about September 12, 2025. The company expects net proceeds of about €592.8 million, which it plans to use mainly to repay revolving loan borrowings under its credit agreement and for general corporate purposes.

  • Notes: €600 million aggregate principal, 4.25% coupon, maturing February 15, 2031, sold at 100 percent of principal
  • Expected net proceeds of approximately €592.8 million after the initial purchasers' discount and offering expenses
  • Proceeds mainly to repay outstanding revolving loan borrowings under the senior secured credit facility; closing expected on or about September 12, 2025
Read the filing on SEC.gov ↗
SSBSouthState Bank Corp Sep 4, 4:41 PM ET

SouthState Bank completes redomicile; assumes $175.9 million trust preferred securities

Neutral restructuring Written later 1.012.012.035.025.03

SouthState Bank Corp completed a merger that redomiciled the company into a new entity, New SSB, which assumed the existing bank's debt and obligations, including a senior revolving credit facility, trust preferred securities and subordinated notes. The officers and directors of the former company became the officers and directors of New SSB, and the new entity operates under new articles and bylaws. The filing reports no change in the financial results and no cash payment to shareholders.

  • New SSB assumed trust preferred securities with an aggregate principal amount of $175.887 million.
  • Subordinated notes assumed include $350 million due 2035, $130 million due 2030 and $175.0 million due August 15, 2034.
  • Merger agreement dated August 19, 2025; the filing is dated September 4, 2025.
  • Former officers and directors of the old company became officers and directors of New SSB.
Read the filing on SEC.gov ↗

M3-Brigade Acquisition VI completes $345 million IPO and places proceeds in trust

Neutral financing Written later 8.01

On August 28, 2025, M3-Brigade Acquisition VI Corp. completed its initial public offering of 34,500,000 units at $10.00 per unit, generating gross proceeds of $345,000,000, including full exercise of the underwriters' over-allotment option. The company, a blank check company with no selected acquisition target, placed the $345,000,000 in a U.S.-based trust account and filed an audited balance sheet as of August 28, 2025 as Exhibit 99.1.

  • 34,500,000 units sold at $10.00 per unit, generating $345,000,000 gross proceeds
  • Private placement of 5,333,333 warrants to the sponsor and Cantor Fitzgerald at $1.50 each, generating $8,000,000
  • Trust account held with Continental Stock Transfer & Trust Company; the company has 24 months from the IPO closing to complete a business combination
  • Balance sheet as of August 28, 2025 shows $1,895,027 in cash and $345,000,000 in trust, with a $16,425,000 deferred underwriting fee
Read the filing on SEC.gov ↗
CDNSCADENCE DESIGN SYSTEMS INC Sep 4, 4:32 PM ET

Cadence to buy Hexagon's design and engineering unit for €2.70 billion

Neutral m&a Written later 1.013.02

Cadence Design Systems agreed on September 4, 2025 to acquire the design and engineering business of Hexagon Smart Solutions AB for an enterprise value of €2.70 billion, including about €810 million paid in newly issued Cadence common stock. Closing is expected in the first quarter of 2026 and is subject to antitrust and foreign investment approvals, and Cadence would owe a reverse termination fee of up to €175 million if regulatory approvals fail.

  • Enterprise value of €2.70 billion, with about €1.89 billion paid in cash and about €810 million in Cadence stock
  • Cash portion to be funded from cash on hand and borrowings under existing debt facilities
  • Closing expected in the first quarter of 2026; outside date September 4, 2026, extendable to March 4, 2027
  • Reverse termination fee of up to €175 million payable by Cadence in certain regulatory failure scenarios
Read the filing on SEC.gov ↗
CARRCARRIER GLOBAL Corp Sep 4, 4:28 PM ET

Carrier Global names Beril Yildiz Vice President, Controller and Chief Accounting Officer

Neutral leadership Written later 5.02

Carrier Global appointed Beril Yildiz as Vice President, Controller and Chief Accounting Officer, effective when she starts on September 22, 2025. Patrick Goris, the company's CFO, has been serving as interim Controller since May 2, 2025 and will hand that role over on her start date while remaining Senior Vice President and Chief Financial Officer.

  • Beril Yildiz, age 47, previously was Senior Vice President, Controller and Chief Accounting Officer at International Flavors & Fragrances from September 2022 to August 2025
  • Yildiz's compensation includes a $500,000 annual base salary, a 60% target annual bonus, a $470,000 annual long-term incentive target, and a $750,000 sign-on equity grant
  • Yildiz also receives an $800,000 cash sign-on award and standard relocation expenses
Read the filing on SEC.gov ↗
CICigna Group Sep 4, 4:08 PM ET

Cigna prices $4.5 billion in senior notes, uses proceeds to repay $2.0 billion loan

Neutral financing Written later 1.012.038.01

Cigna completed a $4.5 billion sale of four series of senior notes maturing from 2030 to 2056. The company said it will use most of the proceeds to repay $2.0 billion of loans under a term loan that funded a strategic investment in another company.

  • Four note series totaling $4.5 billion: $1.0 billion due 2030, $1.25 billion due 2032, $1.5 billion due 2036, and $750 million due 2056
  • Proceeds to repay $2.0 billion outstanding under the Term Loan Agreement dated August 5, 2025; remainder for general corporate purposes
  • Interest rates range from 4.500% to 6.000%, with the 2056 notes carrying the highest rate
Read the filing on SEC.gov ↗
BSXBOSTON SCIENTIFIC CORP Sep 4, 4:07 PM ET

Boston Scientific: EVP Jeffrey Mirviss to retire as Peripheral Interventions head Dec. 1, 2025

Neutral leadership Written later 5.02

Boston Scientific said Executive Vice President and President of Peripheral Interventions Jeffrey B. Mirviss will retire from that role effective December 1, 2025, and will then serve as a senior advisor through February 27, 2026. The company expects to sign a retirement agreement with him with payments and benefits materially consistent with existing plans, which matters to shareholders mainly as a routine leadership transition in one business unit.

  • Mirviss informed the company of his retirement decision on August 29, 2025.
  • Retirement from his executive role takes effect December 1, 2025.
  • He will stay on as a senior advisor until the Retirement Date, no later than February 27, 2026, at his current $705,000 annual base salary, prorated.
  • A Retirement Agreement is expected, with terms materially consistent with existing executive retirement, bonus and long-term incentive plans.
Read the filing on SEC.gov ↗

Coca-Cola Consolidated: EVP Robert Chambless to move to senior advisor role January 1, 2026

Neutral leadership Written later 5.02

Coca-Cola Consolidated said Executive Vice President of Franchise Beverage Operations Robert G. Chambless plans to retire in 2027 and will transition to Executive Vice President, Senior Advisor to the Chairman and CEO, effective January 1, 2026. The filing says the change is not the result of any disagreement with the company on operations, policies, practices, financial statements, accounting policies or internal controls.

  • Robert G. Chambless notified the company of his retirement plans on August 28, 2025.
  • Chambless will move to the Senior Advisor role effective January 1, 2026, and retire in 2027.
  • In the new role he will help with transition matters and serve as strategic advisor to the Chairman and CEO.
  • The filing states no disagreement with the company on financial statements, accounting or internal controls.
Read the filing on SEC.gov ↗
LIVNLivaNova PLC Sep 4, 9:07 AM ET

LivaNova appoints Donald Zurbay to board and Audit and Compliance Committee

Neutral leadership Written later 5.02

LivaNova's board appointed Donald Zurbay, former CEO and CFO of Patterson Companies, as a director effective September 4, 2025, and as a member of the Audit and Compliance Committee. The filing describes his prior roles at Patterson Companies and St. Jude Medical and lists his director compensation, which is prorated until the 2026 Annual General Meeting.

  • Donald Zurbay joins the board and Audit and Compliance Committee; his term begins September 4, 2025.
  • He was President and CEO of Patterson Companies from October 2022 until May 2025, and its CFO from June 2018 to October 2022.
  • Annual compensation includes a $70,000 board retainer, a $15,000 committee member fee, and restricted stock with a fair market value of $185,000, prorated to the 2026 Annual General Meeting.
Read the filing on SEC.gov ↗
GPCGENUINE PARTS CO Sep 4, 8:43 AM ET

Genuine Parts signs Elliott cooperation agreement, adds two independent directors

Neutral leadership Written later 1.015.027.01

Genuine Parts Company entered into a Cooperation Agreement with Elliott Investment Management and appointed Matthew A. Carey and Court D. Carruthers to its Board effective September 4, 2025, while directors John R. Holder and Robin C. Loudermilk, Jr. retired. The filing also discloses new retention restricted stock units and a form of severance agreement for executives, which shareholders may weigh as part of the company's governance changes.

  • Carey and Carruthers joined the Board as independent directors, with initial terms expiring at the 2026 annual meeting; Carey joined the Audit Committee and Carruthers joined the Compensation and Human Capital Committee.
  • Holder and Loudermilk retired from the Board effective September 4, 2025, and the company said their decisions were not due to any disagreement with the company.
  • Retention RSU grants have a grant date value of $3.0 million for CEO Will Stengel and $1.5 million for each of CFO Bert Nappier, Naveen Krishna and Christopher Galla, cliff vesting on the third anniversary of the grant date.
  • The cooperation period runs until the earlier of 30 days before the 2027 annual meeting nomination deadline or September 4, 2026.
Read the filing on SEC.gov ↗
NGVTIngevity Corp Sep 4, 6:45 AM ET

Ingevity to sell CTO refinery and industrial specialties unit to Mainstream Pine for $110 million

Neutral m&a Written later 1.017.01

Ingevity agreed on September 3, 2025, to sell substantially all assets of its industrial specialties product line and its North Charleston crude tall oil refinery to Mainstream Pine Products for $110 million in cash, plus up to $19 million in contingent payments tied to future EBITDA. The company expects the deal to close by early 2026 and says it will reaffirm its full-year 2025 guidance, adjusted for reclassifying the sold assets as discontinued operations.

  • Cash purchase price of $110 million, subject to working capital adjustments, plus contingent consideration of $0 to $19 million
  • Ingevity expects 2025 revenue from the assets being sold to be about $130 million, with EBITDA margins in the low-to-mid single digits
  • Closing expected by early 2026; either party may terminate if the deal is not closed by January 31, 2026
  • Ingevity affirms 2025 guidance of sales of $1.25 billion to $1.40 billion and adjusted EBITDA of $390 million to $415 million, excluding the reclassification
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.